Evidence map›Paper›PMID 39036546›Full record

ReviewJournal of the National Cancer Center2022

Towards automated organs at risk and target volumes contouring: Defining precision radiation therapy in the modern era.

Dakai Jin, Dazhou Guo, Jia Ge, Xianghua Ye, Le Lu

Abstract readReview
In one paragraph

Review in Journal of the National Cancer Center, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Educational Impact of a National Training Webinar on AI-based Automatic Contouring in Radiation Oncology.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dakai JinDAMO Academy, Alibaba Group, New York, United States.
Dazhou GuoDAMO Academy, Alibaba Group, New York, United States.
Jia GeDepartment of Radiation Oncology, The First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Xianghua YeDepartment of Radiation Oncology, The First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Le LuDAMO Academy, Alibaba Group, New York, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precision radiotherapy is a critical and indispensable cancer treatment means in the modern clinical workflow with the goal of achieving "quality-up and cost-down" in patient care. The challenge of this therapy lies in developing computerized clinical-assistant solutions with precision, automation, and reproducibility built-in to deliver it at scale. In this work, we provide a comprehensive yet ongoing, incomplete survey of and discussions on the recent progress of utilizing advanced deep learning, semantic organ parsing, multimodal imaging fusion, neural architecture search and medical image analytical techniques to address four corner-stone problems or sub-problems required by all precision radiotherapy workflows, namely, organs at risk (OARs) segmentation, gross tumor volume (GTV) segmentation, metastasized lymph node (LN) detection, and clinical tumor volume (CTV) segmentation. Without loss of generality, we mainly focus on using esophageal and head-and-neck cancers as examples, but the methods can be extrapolated to other types of cancers. High-precision, automated and highly reproducible OAR/GTV/LN/CTV auto-delineation techniques have demonstrated their effectiveness in reducing the inter-practitioner variabilities and the time cost to permit rapid treatment planning and adaptive replanning for the benefit of patients. Through the presentation of the achievements and limitations of these techniques in this review, we hope to encourage more collective multidisciplinary precision radiotherapy workflows to transpire.

Indexed as

Organs at riskRadiation therapyTarget tumor volume

Identifiers

PMID39036546
PMCPMC11256697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.